The Fertility Show, Manchester Central, 24-25 March 2018
Page URL:

Kirsty Oswald

Kirsty Oswald is a Volunteer Writer at BioNews. She was previously Genetics Editor at BioNews and at the charity that publishes it, the Progress Educational Trust (PET). She originally studied Human Sciences at University College London, and went on to work as a healthcare copywriter and as a medical journalist at medwireNews. She has a particular interested in the social and cultural aspects of science, and she tweets as @kirstyoswald

BioNews Comment articles written by Kirsty Oswald:
Page 1 of 1
Beating the biological clock - should you freeze your eggs?
26 October 2015 - by Kirsty Oswald
Will egg freezing enable women to take full reproductive control and beat the biological clock? Or is it just another way to tell women they can't have a career and a family? These were some of the questions tackled at PET's recent event 'Beating the Biological Clock: should you freeze your eggs?'... [Read More]
Ageing and fertility: biology comes second
10 August 2015 - by Kirsty Oswald
All this talk of the age a woman's fertility 'drops off a cliff' is just a distractor from the truth – this phenomenon of women finding themselves 'up against' the biological clock is a cultural one, not a biological one.... [Read More]
Good eggs, bad sperm and terrible journalism
2 March 2015 - by Kirsty Oswald
You may have come across the story. 'Teenagers more likely to pass on genetic mutations to children,' reported The Independent. But was there research showing anything of the sort? The simple answer is no... [Read More]

BioNews News articles written by Kirsty Oswald:
Page 1 of 3
CRISPR-like immune system found in giant virus
7 March 2016 - by Kirsty Oswald
Researchers have found that mimiviruses, a class of giant viruses, have an immune system reminiscent of the CRISPR system used by bacteria to evade infection... [Read More]
Stem-cell controversy unfolds in Sweden
15 February 2016 - by Kirsty Oswald
The world-renowned Karolinska Institute is at the centre of a scandal surrounding the conduct of stem-cell surgeon Paulo Macchiarini... [Read More]
Panel recommends FDA approval of mitochondrial donation
8 February 2016 - by Kirsty Oswald
Clinical investigations of mitochondrial donation are 'ethically permissable', says a panel of experts reporting to the US Food and Drug Administration... [Read More]
Gene mutations can predict prostate cancer drug resistance
9 November 2015 - by Kirsty Oswald
Researchers have identified the genetic mutations that drive resistance to the hormone therapy abiraterone in patients with advanced prostate cancer... [Read More]
India moves to curb commercial surrogacy
19 October 2015 - by Kirsty Oswald
India looks poised to introduce surrogacy legislation following several developments that could lead to a blanket ban on commercial surrogacy... [Read More]
North East Essex CCG cuts IVF funding
5 October 2015 - by Kirsty Oswald
North East Essex Clinical Commissioning Group has announced that it is ending its IVF funding, and fertility treatment will only be available to specific groups of patients... [Read More]
NHS England sets out personalised medicine strategy
28 September 2015 - by Kirsty Oswald
NHS England's national medical director, Sir Bruce Keogh, has outlined how the organisation's approach to personalised medicine will develop over the coming years and expand beyond the work of the 100,000 Genomes Project... [Read More]
UK scientists seek permission to edit embryos
21 September 2015 - by Kirsty Oswald
Researchers from London's Francis Crick Institute are seeking permission to edit the genome of human embryos... [Read More]
Gene editing of human embyros must be allowed, says Hinxton group
14 September 2015 - by Kirsty Oswald
The influential Hinxton group has said that the genetic modification of human embryos should be allowed... [Read More]
Young breast cancer patients forgo tamoxifen over fertility concerns
1 September 2015 - by Kirsty Oswald
Researchers in the USA have found that fertility concerns may be contributing to low tamoxifen use and discontinuation of the drug among reproductive-age breast cancer patients... [Read More]